BACKGROUND: Dialysis-requiring acute kidney injury (AKI-D) is a documented complication of hospitalization and procedures. Temporal incidence of AKI-D and related hospital mortality in the US population has not been recently characterized. We describe the epidemiology of AKI-D as well as associated in-hospital mortality in the US. METHODS: Retrospective cohort of a national discharge data (n = 86,949,550) from the Healthcare Cost and Utilization Project's National Inpatient Sample, 2001-2011 of patients' hospitalization with AKI-D. Primary outcomes were AKI-D and in-hospital mortality. We determined the annual incidence rate of AKI-D in the US from 2001 to 2011. We estimated ORs for AKI-D and in-hospital mortality for each successive year compared to 2001 using multiple logistic regression models, adjusted for patient and hospital characteristics, and stratified the analyses by sex and age. We also calculated population-attributable risk of in-hospital mortality associated with AKI-D. RESULTS: The adjusted odds of AKI-D increased by a factor of 1.03 (95% CI 1.02-1.04) each year. The number of AKI-D-related (19,886-34,195) in-hospital deaths increased almost 2-fold, although in-hospital mortality associated with AKI-D (28.0-19.7%) declined significantly from 2001 to 2011. Over the same period, the adjusted odds of mortality for AKI-D patients were 0.60 (95% CI 0.56-0.67). Population-attributable risk of mortality associated with AKI-D increased (2.1-4.2%) over the study period. CONCLUSIONS: The incidence rate of AKI-D has increased considerably in the US since 2001. However, in-hospital mortality associated with AKI-D hospital admissions has decreased significantly.
BACKGROUND:Dialysis-requiring acute kidney injury (AKI-D) is a documented complication of hospitalization and procedures. Temporal incidence of AKI-D and related hospital mortality in the US population has not been recently characterized. We describe the epidemiology of AKI-D as well as associated in-hospital mortality in the US. METHODS: Retrospective cohort of a national discharge data (n = 86,949,550) from the Healthcare Cost and Utilization Project's National Inpatient Sample, 2001-2011 of patients' hospitalization with AKI-D. Primary outcomes were AKI-D and in-hospital mortality. We determined the annual incidence rate of AKI-D in the US from 2001 to 2011. We estimated ORs for AKI-D and in-hospital mortality for each successive year compared to 2001 using multiple logistic regression models, adjusted for patient and hospital characteristics, and stratified the analyses by sex and age. We also calculated population-attributable risk of in-hospital mortality associated with AKI-D. RESULTS: The adjusted odds of AKI-D increased by a factor of 1.03 (95% CI 1.02-1.04) each year. The number of AKI-D-related (19,886-34,195) in-hospital deaths increased almost 2-fold, although in-hospital mortality associated with AKI-D (28.0-19.7%) declined significantly from 2001 to 2011. Over the same period, the adjusted odds of mortality for AKI-D patients were 0.60 (95% CI 0.56-0.67). Population-attributable risk of mortality associated with AKI-D increased (2.1-4.2%) over the study period. CONCLUSIONS: The incidence rate of AKI-D has increased considerably in the US since 2001. However, in-hospital mortality associated with AKI-D hospital admissions has decreased significantly.
Authors: Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh Journal: Clin J Am Soc Nephrol Date: 2014-01-23 Impact factor: 8.237
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Tariq Ali; Izhar Khan; William Simpson; Gordon Prescott; John Townend; William Smith; Alison Macleod Journal: J Am Soc Nephrol Date: 2007-02-21 Impact factor: 10.121
Authors: Raymond K Hsu; Charles E McCulloch; R Adams Dudley; Lowell J Lo; Chi-yuan Hsu Journal: J Am Soc Nephrol Date: 2012-12-06 Impact factor: 10.121
Authors: Raymond K Hsu; Charles E McCulloch; Elaine Ku; R Adams Dudley; Chi-Yuan Hsu Journal: Clin J Am Soc Nephrol Date: 2013-08-08 Impact factor: 8.237
Authors: Orfeas Liangos; Ron Wald; John W O'Bell; Lorilyn Price; Brian J Pereira; Bertrand L Jaber Journal: Clin J Am Soc Nephrol Date: 2005-10-26 Impact factor: 8.237
Authors: Elaine Ku; Raymond K Hsu; Kirsten L Johansen; Charles E McCulloch; Mark Mitsnefes; Barbara A Grimes; Kathleen D Liu Journal: PLoS Med Date: 2021-02-19 Impact factor: 11.069
Authors: Amay Parikh; John A Rizzo; Pietro Canetta; Catherine Forster; Meghan Sise; Omar Maarouf; Eugenia Singer; Antje Elger; Saban Elitok; Kai Schmidt-Ott; Jonathon Barasch; Thomas L Nickolas Journal: PLoS One Date: 2017-05-19 Impact factor: 3.240
Authors: Benjamin R Griffin; Zhiying You; John Holmen; Megan SooHoo; Katja M Gist; James F Colbert; Michel Chonchol; Sarah Faubel; Anna Jovanovich Journal: PLoS One Date: 2019-06-24 Impact factor: 3.240
Authors: Chandan Vangala; Maulin Shah; Natasha N Dave; Layth Al Attar; Sankar D Navaneethan; Venkat Ramanathan; Susan Crowley; Wolfgang C Winkelmayer Journal: Ren Fail Date: 2021-12 Impact factor: 2.606